NCT02628392View on ClinicalTrials.gov

A Phase 2 Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)

NACompletedINTERVENTIONAL
Enrollment

368

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Type2 Diabetes Mellitus
Interventions
DRUG

DS-8500a

DS-8500a tablets 25mg, 50mg, 75mg

DRUG

Sitagliptin

capsules

DRUG

placebo

matching DS-8500a tablets and sitagliptin capsules

Trial Locations (1)

Unknown

Heishinkai Medical Group Incorporated OCROM Clinic, Suita-shi

Sponsors
All Listed Sponsors
lead

Daiichi Sankyo Co., Ltd.

INDUSTRY

NCT02628392 - A Phase 2 Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM) | Biotech Hunter | Biotech Hunter